BioNTech to Report First Quarter 2026 Financial Results and Corporate Update on May 5, 2026

Rhea-AI Summary

BioNTech (Nasdaq: BNTX) will report first quarter 2026 financial results on May 5, 2026 and host a conference call and webcast at 8:00 a.m. ET / 2:00 p.m. CET.

Investors should register in advance to receive dial‑in numbers and a PIN; slides and audio will be available on the company website and a replay will be archived for 30 days.

News Market Reaction – BNTX

+6.09% 2.7x vol

32 alerts

+6.09% Session close to close

+2.7% Peak in 5 hr 10 min

$28.47B Market Cap

2.7x Rel. Volume

In the Apr 21 session, BNTX gained 6.09%, reflecting a notable positive market reaction. Argus tracked a peak move of +2.7% during that session. Our momentum scanner triggered 32 alerts that day, indicating elevated trading interest and price volatility. Trading volume was elevated at 2.7x the daily average, suggesting notable buying interest.

Data tracked by StockTitan Argus on the day of publication.

Market Context

The stock moved +6.1% in the session following this news. A strong positive reaction aligns with the...

Analysis

The stock moved +6.1% in the session following this news. A strong positive reaction aligns with the pattern that even routine earnings date notices have coincided with constructive sentiment, such as the prior 0.87% move after the last scheduling update. However, earnings timing alone does not change fundamentals; subsequent Q4/FY 2025 results and guidance still drove larger swings. Investors would need to weigh the upcoming Q1 2026 details and any updated oncology milestones when assessing how durable a post-announcement surge might be.

Key Figures

Quarter reported: First quarter 2026 Earnings date: May 5, 2026 Conference call time (ET): 8:00 a.m. ET +2 more

5 metrics

Quarter reported First quarter 2026 Period for upcoming financial results

Earnings date May 5, 2026 Scheduled Q1 2026 results announcement

Conference call time (ET) 8:00 a.m. ET Start time of earnings call

Conference call time (CET) 2:00 p.m. CET Start time of earnings call

Webcast archive period 30 days Duration replay will be available

Previous Earnings date Reports

1 past event · Latest: Feb 24 (Neutral)

Same Type Pattern 1 events

Date	Event	Sentiment	24h Move	Catalyst
Feb 24	Earnings date notice	Neutral	+0.9%	Announced timing and access details for Q4 and FY 2025 results call.

24h Move is the share-price change in the day after each event; other market factors may also have contributed.

Pattern Detected

Limited same-tag history: the prior earnings date notice saw a modest positive move of 0.87%, suggesting these scheduling updates have had low but positive impact.

Recent Company History

Over recent months, BioNTech has combined financial communication with a growing oncology focus. The last earnings date notice on Feb 24, 2026 preceded fourth quarter and full-year 2025 results and a 0.87% price gain. Subsequent announcements covered 2025 financials, 2026 guidance and a strategic co-founders spin-out concept, as well as late-stage lung cancer data. Today’s first quarter 2026 earnings date fits the pattern of regular, structured investor updates alongside an expanding clinical pipeline.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

MAINZ, Germany, April 21, 2026 (GLOBE NEWSWIRE) -- BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial results for the first quarter 2026 on Tuesday, May 5, 2026. Additionally, the Company will host a conference call and webcast that day at 8:00 a.m. ET (2:00 p.m. CET) for investors, financial analysts and the general public to discuss its financial results and provide a corporate update.

To access the live conference call via telephone, please register via this link. Once registered, dial-in numbers and a PIN will be provided. It is recommended to register at least one day in advance. The slide presentation and audio of the webcast will be available via this link.

Participants may also access the slides and the webcast of the conference call via the “Events & Presentations” page in the Investor Relations section of the Company’s website at www.BioNTech.com. A replay of the webcast will be made available shortly after the call and archived on the Company’s website for 30 days following the call.

About BioNTech
Biopharmaceutical New Technologies (BioNTech) is a global next generation immunotherapy company pioneering novel investigative therapies for cancer and other serious diseases. BioNTech exploits a wide array of computational discovery and therapeutic modalities with the intent of rapid development of novel biopharmaceuticals. Its diversified portfolio of oncology product candidates aiming to address the full continuum of cancer includes mRNA cancer immunotherapies, next-generation immunomodulators and targeted therapies such as antibody-drug conjugates (ADCs) and innovative chimeric antigen receptor (CAR) T cell therapies. Based on its deep expertise in mRNA development and in-house manufacturing capabilities, BioNTech and its collaborators are researching and developing multiple mRNA vaccine candidates for a range of infectious diseases alongside its diverse oncology pipeline. BioNTech has established a broad set of relationships with multiple global and specialized pharmaceutical collaborators, including Bristol Myers Squibb, Duality Biologics, Genentech, a member of the Roche Group, Genmab, MediLink, OncoC4, Pfizer and Regeneron.

For more information, please visit www.BioNTech.com.

CONTACTS

Investor Relations
Douglas Maffei, PhD
Investors@biontech.de

Media Relations
Jasmina Alatovic
Media@biontech.de

FAQ

When will BioNTech (BNTX) release its Q1 2026 financial results and hold the earnings call?

BioNTech will release Q1 2026 results and host the call on May 5, 2026 at 8:00 a.m. ET. According to the company, the event includes a webcast and conference call with slides accessible on the investor relations website and a replay available for 30 days.

How can investors register for the BioNTech (BNTX) May 5, 2026 conference call and webcast?

Investors should register via the provided registration link at least one day before the call. According to the company, registrants will receive dial‑in numbers and a PIN; the slide presentation and audio will be available through the webcast and investor relations site.

What time is BioNTech's (BNTX) May 5, 2026 webcast for Q1 2026 results in CET and ET?

The webcast is scheduled for 8:00 a.m. ET, which is 2:00 p.m. CET, on May 5, 2026. According to the company, the event will include a corporate update and investor Q&A, with slides and a replay archived on the company website for 30 days.

Where will the BioNTech (BNTX) slide presentation and replay be posted after the May 5, 2026 call?

The slide presentation and replay will be posted on BioNTech's investor relations website under Events & Presentations. According to the company, the replay will be available shortly after the call and archived for 30 days following the event.

Can the public and analysts access BioNTech's (BNTX) May 5, 2026 earnings webcast without attending live?

Yes; a replay will be available and archived for 30 days on the company website. According to the company, slides and audio are posted after the live webcast for those who cannot join live.

Will BioNTech (BNTX) provide a Q&A during the May 5, 2026 conference call for investors and analysts?

The company will host a conference call and webcast intended for investors, analysts and the public that typically includes a Q&A segment. According to the company, participants can access the call by registering to receive dial‑in details and a PIN.